HBW Insight：可持续包装

SustainablePackaging We spoke to PA Consulting’s Tony Perrotta in an episodeof HBW Insight’s “Over the Counter” podcast — includedherein — who predicted the Collective’s first dry moldedfiber blister packs could reach the market in some formwithin the next two years. ` they contain chlorine, are potentially harmful to theenvironment if not disposed of correctly. Foreword As discussed in the first three articles in thisHBW InsighteBook, medicine and medical device packaging have sofar been excluded from targets set by the EuropeanUnion’s proposed Packaging and Packaging WasteRegulation, currently in trilogue negotiations, which holdsthat all packaging should be recyclable by 2030. According to UK-basedenvironmental NGO WRAP (Wasteand Resources Action Program),about a third of the 141 million tons of plasticpackaging produced every year leaks fromcollection systems into the environment. On the other hand, packaging suppliers such asLogoplaste are skeptical that industry will be able to partways with plastics. The key is working out how to recyclethem, the firm’s chief technology officer Paulo Correiainsists. It is looking like medicines will be exempt until at least2035, at which point the European Commission maycheck whether alternative materials and recyclingtechnologies have advanced to a point where theexemption should be reconsidered. Further, plastic production, use, and disposal createabout 1.8 billion tons of carbon emissions annually,contributing significantly to global warming. Currently, the national recycling infrastructure is impedingprogress, as existing programs are not equipped tosupport a circular economy in medical plastics. Increasingly, the consumer health industry is underscrutiny as public pressure and regulatory requirementsmount to improve transparency around plastic use anddrive replacement, reduction, and reuse of plasticmaterials. The prospect of eliminating plastics from medicinepackaging entirely is a subject of intense debate withinindustry, and between manufacturers and theirpackaging suppliers. To modernize these systems, companies may have toaccept the “polluter pays” principle behind extendedproducer responsibility (EPR) schemes, which askcompanies to cover waste management and recyclingcosts. On the one hand, industry is exploring alternatives, withHaleon, Bayer Consumer Health, and Sanofi ConsumerHealthcare all backing PA Consulting’s Blister PackCollective, which is looking at how to commercializePulPac’s sustainable blister packs. A particularly tricky problem facing the industry ismaking medicine blister packs sustainable. The proof is in the pudding, says Filipe Vieira de Castro ofrecycling giant Veolia Group. “The tangible impact of EPRis evident in the uptick of recycling rates in countries thathave adopted such policies.” Traditionally made from polyvinyl chloride (PVC), blisterpacks are hard to recycle due to their size and, because Contents REGULAREGULATITIONON INTERINTERVIEWVIEWSS EXAMPLESEXAMPLES EU Parliament Stricter Than Council onMedicines and Medical Devices Packaging Kenvue Prioritizes Plastics as Part of HealthyLives Mission Haleon Smashes Toothpaste Tube RecyclingTarget Medicines and Medical Devices Should BeExempt from New Plastic Packaging RulesSays EU Council There’s ‘No Silver Bullet’ for MakingMedicines Packaging Sustainable Sanofi Joins Push for Plastic-free BlisterPacks Plastic Packaging: The Search forAlternatives Must Be Pragmatic NotEmotionally Driven Unilever Adjusts Sustainable Plastic Goals asIndustry Aspirations Meet Systemic Realities AESGP Meeting: Medicine PackagingExemption ‘Not Helpful’ for Circular Economy Over The Counter: Solving the Sustainable PillPack Puzzle, with PA Consulting’s TonyPerrotta Regulation EU Parliament Stricter Than Council onMedicines and Medical Devices Packaging EU Parliament StricterThan Council onMedicines and MedicalDevices Packaging The EU Parliament's Environment, Public Health and FoodSafety committee takes a compromise position withregards to the Packaging and Packaging Waste Directive(PPWD). Medicines and medical devices should be exempt,but only until 2035, at which point the EuropeanCommission should check whether the development ofmaterials and the recycling process have progressed, andmay adjust this exemption accordingly. commented. “Therefore, it is important thatthese product groups are exempted fromthe recycling obligation at least until 2035,as suitable materials are currently notavailable.” The EuropeanParliament’s Committeeon the Environment,Public Health and Food Safety(ENVI) wants medicines andmedical devices to be exemptfrom new packaging rulesproposed within the Packagingand Packaging Waste Directive. Technological progress may mean theexemption will be lifted in 2035, most likelywith an additional transitional period, BAHnoted. “We are already supporting ourmembers on this path,” it said. … in cases where it has to comply withspecific requirements to p